Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Receivables - Net: 2024

Historic Receivables - Net for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $13.9 million.

  • Day One Biopharmaceuticals' Receivables - Net rose 92.03% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year increase of 92.03%. This contributed to the annual value of $13.9 million for FY2024, which is N/A change from last year.
  • Day One Biopharmaceuticals' Receivables - Net amounted to $13.9 million in FY2024.
  • In the past 5 years, Day One Biopharmaceuticals' Receivables - Net ranged from a high of $13.9 million in FY2024 and a low of $13.9 million during FY2024.
  • Over the past 1 years, Day One Biopharmaceuticals' median Receivables - Net value was $13.9 million (recorded in 2024), while the average stood at $13.9 million.